Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment

Journal of Palliative Medicine

Volumn 16, Issue 4, 2013, Pages 455-458

  Hauer, Julie ^a   MacKey, Daniel ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CarePartners Health Services and Carolina Pediatric Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; METOCLOPRAMIDE; MORPHINE SULFATE; PROTON PUMP INHIBITOR; SILDENAFIL;

ABSENCE OF SIDE EFFECTS; APNEA; ARTICLE; BRADYCARDIA; BRAIN INJURY; BREATHING PATTERN; CASE REPORT; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENCEPHALOMALACIA; EVENING DOSAGE; FEMALE; FLUSHING; FUNCTIONAL RESIDUAL CAPACITY; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK INFANT; HUMAN; INFANT; IRRITABILITY; MUSCLE HYPERTONIA; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN DESATURATION; PAIN THRESHOLD; PALLIATIVE THERAPY; PHYSICAL EXAMINATION; PULMONARY HYPERTENSION; RESTLESSNESS; SPASTICITY; SUDDEN DEATH; TREATMENT DURATION;

AMINES; ANALGESICS; APNEA; CENTRAL NERVOUS SYSTEM; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MUSCLE HYPERTONIA; PAIN; TREATMENT OUTCOME;

EID: 84875861770     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0103     Document Type: Article

References (25)

1. Slocum C, Arko M, Di Fiore J, Martin RJ, Hibbs AM: Apnea, bradycardia and desaturation in preterm infants before and after feeding. J Perinatol 2009;29:209-212.
2. Di Fiore J, Arko M, Herynk B, Martin R, Hibbs AM: Characterization of cardiorespiratory events following gastroesophageal reflux in preterm infants. J Perinatol 2010;30: 683-687.
3. Arad-Cohen N, Cohen A, Tirosh E: The relationship between gastroesophageal reflux and apnea in infants. J Pediatr 2000;137:321-326.
4. Hunt A, Goldman A, Seers K, Crichton N, Mastroyannopoulou K, Moffat V, Oulton K, Brady M: Clinical validation of the paediatric pain profile. Dev Med Child Neurol 2004;46:9-18.
5. Breau LM, Camfield C, McGrath PJ, Rosmus C, Finley GA: Measuring pain accurately in children with cognitive impairments: Refinement of a caregiver scale. J Pediatr 2001; 138:721-727.
6. Malviya S, Voepel-Lewis T, Burke C, Merkel S, Tait AR: The revised FLACC observational pain tool: Improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth 2006;16:258-265.
7. Breau LM, McGrath PJ, Camfield CS, Finley A: Psychometric properties of the non-communicating children's pain checklist-revised. Pain 2002;99:349-357.
8. Stallard P, Williams L, Velleman R, Lenton S, McGrath PJ: Brief report: behaviors identified by caregivers to detect pain in noncommunicating children. J Pediatr Psychol 2002;27: 209-214.
9. Breau LM, McGrath PJ, Camfield C, Rosmus C, Finley GA: Preliminary validation of an observational pain checklist for persons with cognitive impairments and inability to communicate verbally. Dev Med Child Neurol 2000;42:609-616.
10. McCarty SF, Gaebler-Spira D, Harvey RL: Improvement of sleep apnea in a patient with cerebral palsy. Am J Phys Med Rehabil 2001;80:540-542.
11. Hauer J: Identifying and managing sources of pain and distress in children with neurological impairment. Pediatr Ann 2010;39:198-205.
12. Nicholson BD: Evaluation and treatment of central pain syndromes. Neurology 2004;62(5 Suppl 2):S30-36.
13. Frese A, Husstedt IW, Ringelstein EB, Evers S: Pharmacologic treatment of central post-stroke pain. Clin J Pain 2006;22:252-260.
14. Klit H, Finnerup NB, Jensen TS: Central post-stroke pain: Clinical characteristics, pathophysiology, and management. Lancet Neurol 2009;8:857-868.
15. Canavero S, Bonicalzi V: Central Pain Syndrome: Pathophysiology, Diagnosis, and Management. New York: Cambridge University Press, 2007, pp. 48.
16. Delgado-Aros S, Camilleri M: Visceral hypersensitivity. J Clin Gastroenterol 2005;39(Suppl 3):S194-S203.
17. Zangen T, Ciarla C, Zangen S, Di Lorenzo C, Flores AF, Cocjin J, Reddy SN, Rowhani A, Schwankovsky L, Hyman PE: Gastrointestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers. J Pediatr Gastroenterol Nutr 2003;37:287-293.
18. Carter B, McArthur E, Cunliffe M: Dealing with uncertainty: parental assessment of pain in their children with profound special needs. J Adv Nurs 2002;38:449-457.
19. Breau LM, Camfield CS, McGrath PJ, Finley A: The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med 2003;157:1219-1226.
20. Houlihan CM, O'Donnell M, Conaway M, Stevenson RD: Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol 2004;46:305-310.
21. Hasler ML: Pharmacotherapy for intestinal motor and sensory disorders. Gastroenterol Clin North Am 2003;32:707-732.
22. Lee KJ, Kim JH, Cho SW: Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:981-988.
23. Cutter N, Scott DD, Johnson JC: Gabapentin effect on spasticity in multiple sclerosis: A placebo-controlled, randomized trial. Arch Phys Med Rehabil 2000;81:164-169.
24. Hauer J, Wical B, Charnas L: Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment. Pediatrics 2007;119:e519-522.
25. Haney AL, Garner SS, Cox TH: Gabapentin therapy for pain and irritability in a neurologically impaired infant. Pharmacotherapy 2009;29:997-1001.